Phase 1

Phase 1 Study of SPT-2101 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere’s Disease

August 30, 2023

https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12621000964819

Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere’s Disease

December 19, 2020

https://clinicaltrials.gov/ct2/show/NCT04674735

Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere’s Disease

Back to top